While age and performance status, in addition to extent of resection (EOR) and methylguanine-DNA methyltransferase (MGMT) promoter methylation status, are well-established prognostic factors, sex and other demographic factors have been recently shown to predict for outcomes in GBM [8,9,10,11,12]. This evidence concerns the gene MGMT and glioblastoma.